CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 164 enrolled
Drug / intervention
RetHe measurement (Sysmex)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03500497
NCT03500497N/ACompleted

The Change in RetHe - Levels Perioperatively in a Cohort of Colorectal Surgery Patient: it's Role in Perioperative Hemoglobin Optimization

Maastricht University Medical Center·observational·Posted Apr 18, 2018·Updated Jan 4, 2019

In Brief

An observational study evaluating RetHe measurement (Sysmex) for Anemia and 2 related conditions. Completed, enrolled 164 participants across 1 site.

Detailed Summary

During a period of a year, reticulocyte hemoglobin content (RetHe) measurements (Sysmex) are done out of blood samples taken on several occasions during normal patient care: 1. preoperatively at the surgical or anesthetic outpatient visit 2. on admission or pre- induction of anesthesia 3. postoperatively at the postanesthetic care unit 4. on day 3 postoperatively 5. on day 5 postoperatively Additionally a Quality of Life (QoL) questionnaire will be taken from the participants before surgery and 30 days after surgery to evaluate the course of QoL perioperatively.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesNetherlands
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 18, 2018
Enrollment StartAug 25, 2017
Primary CompletionNov 7, 2018
Study CompletionJan 2, 2019
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 8.2 years ago

Interventions

RetHe measurement (Sysmex)other

RetHe measurement is done from blood samples gained during standard patient care perioperatively